Holen Sie sich die Stockscreener-App
111.70
1.38%
-1.56
Handel nachbörslich:
111.70
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$113.26
Offen:
$112.3
24-Stunden-Volumen:
1.41M
Relative Volume:
0.64
Marktkapitalisierung:
$31.57B
Einnahmen:
$7.07B
Nettoeinkommen (Verlust:
$1.29B
KGV:
24.63
EPS:
4.5355
Netto-Cashflow:
$993.00M
1W Leistung:
-3.39%
1M Leistung:
-6.74%
6M Leistung:
-23.92%
1J Leistung:
-0.62%
1-Tages-Spanne:
$111.44
$113.08
1-Wochen-Bereich:
$111.09
$115.85
52-Wochen-Spanne:
$107.07
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent Tech Q2 Net Drops, Job Cuts and Share Repurchase Widening Announced - AOL.com
Agilent Deepens India Biologics Ties While Targeting High Speed Debugging - Yahoo Finance
What makes Agilent (A) a new buy stock - MSN
TRADE NEWS: Agilent Technologies Introduces Industry's First LTE-Advanced 8x8 MIMO Signal-Generation - AOL.com
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
AAgilent Technologies Inc Stock Price and Quote - Finviz
Agilent $40M Expansion Doubles Chicopee Manufacturing Site - Hoodline
Agilent Technologies opens new Chicopee manufacturing facility - The Reminder
Agilent invests $40M to double Massachusetts manufacturing site - The Business Journals
What Makes Agilent (A) a New Buy Stock - Yahoo Finance
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a cent as guidance points t - AD HOC NEWS
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a hair while revenue rises - AD HOC NEWS
Global company Agilent Technologies opens new Chicopee site - WWLP
TRADE NEWS: Agilent Technologies Introduces New Portable Logic Analyzers - AOL.com
Agilent Technologies stock (US00846U1016): Recent patent ruling and market updates - AD HOC NEWS
Agilent & Veeda Lifesciences Strengthen Biopharma Analytics with New Facility - Digital Health News
Agilent Technologies (A) Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story - Sahm
Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp. - marketscreener.com
Agilent and Veeda Lifesciences open joint analytical Centre of Excellence in Bengaluru - BioSpectrum India
Agilent Technologies Inc. stock (US00846U1016): Short interest rises amid market pressures - AD HOC NEWS
Agilent And Veeda Lifesciences Launch Joint Analytical Center Of Excellence To Accelerate GLP‑1 And Complex Biologics Development Services. - TRIPURA STAR NEWS
Agilent and Veeda Lifesciences Launch Joint Analytical CoE to Accelerate GLP‑1 and Complex Biologics Development Services - Indianweb2.com
Agilent Technologies or Danaher: Which Stock Has More Upside? - Trefis
Agilent Technologies to Present at Jefferies Healthcare Conference on June 4, 2026, at 9:00 AM ET - geneonline.com
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent (A) SVP Simon May surrenders 368 shares to cover RSU tax bill - Stock Titan
Here's what to expect from Agilent Technologies’ next earnings report - MSN
C-CAMP announces expansion of tie-up with Agilent - The Hindu
Agilent and C‑CAMP Expand Collaboration to Boost India’s Biopharma Research Infrastructure - Indianweb2.com
Agilent expands collaboration with C-CAMP to scale access to advanced life sciences analytics - BioSpectrum India
Agilent to Participate in Jefferies Global Healthcare Conference 2026 - BioSpace
Agilent to Participate in Jefferies Global Healthcare Conference - The National Law Review
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent Technologies stock (US00846U1016): Q1 earnings miss and upcoming Q2 report - AD HOC NEWS
Agilent Technologies stock (US00846U1016): Q1 earnings miss and updated guidance - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors - DirectorsTalk Interviews
Crossmark Global Holdings Inc. Acquires 9,615 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo Finance
Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals? - simplywall.st
FDA approves Agilent PD-L1 test for esophageal cancer - SelectScience
Agilent Technologies Inc. stock (US00846U1016): FDA approval and earnings miss shape outlook - AD HOC NEWS
Generali Asset Management SPA SGR Has $7.38 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
TRADE NEWS: Agilent Technologies' Model Extraction and Qualification Software Adopted by Shanghai Co - Yahoo
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
[Form 3] AGILENT TECHNOLOGIES, INC. Initial Statement of Beneficial Ownership - Stock Titan
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows - Manufacturing Chemist
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Swedbank AB Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing - Indian Pharma Post
Robeco Schweiz AG Has $142.75 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agilent Technologies Inc-Aktie (A) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gonsalves Rodney | V.P., Corporate Controller |
Nov 26 '25 |
Sale |
154.99 |
3,000 |
464,956 |
31,846 |
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):